Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Advanced Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03246048
What this trial is testing

Long Term Follow-up of Hepatitis C Cured Patients

Who this might be right for
Chronic Hepatitis CChronic Liver DiseaseCirrhosis
Hospital Universitari Vall d'Hebron Research Institute 300
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT02628717
What this trial is testing

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)

Who this might be right for
Chronic Hepatitis CCirrhosis
Medical University of Vienna 558
Testing effectiveness (Phase 2)Looking for participantsNCT07791043
What this trial is testing

Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)

Who this might be right for
Liver Diseases, Alcoholic
GlaxoSmithKline 274
Large-scale testing (Phase 3)Study completedNCT00687349
What this trial is testing

Improving Clinician Communication Skills (ICCS)

Who this might be right for
Advanced CancerChronic Obstructive Pulmonary Disease (COPD)Restrictive Lung Disease+2 more
University of Washington 6,086
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableStudy completedNCT00252642
What this trial is testing

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

Who this might be right for
Hepatitis CCirrhosisFibrosis
Virginia Commonwealth University 60
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT05044663
What this trial is testing

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 325
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT04099407
What this trial is testing

Pirfenidone and Advanced Liver Fibrosis.

Who this might be right for
Liver FibrosisChronic Liver Disease
Grupo Mexicano para el Estudios de las Enfermedades Hepaticas 122
Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Not applicableUnknownNCT03315767
What this trial is testing

Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES)

Who this might be right for
Hypertension, Portal
University of Ulm 45
Testing effectiveness (Phase 2)Study completedNCT01658878
What this trial is testing

An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 657
Post-approval studies (Phase 4)Study completedNCT02907749
What this trial is testing

Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis

Who this might be right for
CirrhosisPortal Hypertension
Changqing Yang 96
Testing effectiveness (Phase 2)Study completedNCT01938430
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Who this might be right for
Chronic HCV Infection
Gilead Sciences 339
Not applicableStudy completedNCT03778411
What this trial is testing

Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

Who this might be right for
Advanced Chronic Liver Disease, NASH
Indiana University 298
Not applicableUnknownNCT06147934
What this trial is testing

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

Who this might be right for
Liver FibrosisLiver Cirrhosis
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Next Page